2653 monitored
← Actor desksRead-only · existing recordsClassic graph view ↗

Sentinels / Actor desk

Thoraia Hussein

person · Registry status: unverified

0f3d3367-da23-5e29-ba36-17d196e95f32

Evidence, not intent.

Public-source event mentions and stored signals. Adjacency does not establish causation, coordination, or an actor's position.

No claim of complete coverage or live monitoring.

Observation window

UTC dates, inclusive · maximum 90 days. Applies to events and anomalies only.

Recent observations / timeline

The source record

91 distinct events shown, newest first. Headlines may be generated summaries; inspect the source before repeating a claim.

  1. terrorism-info.org.il: Ahmed Muhanna, Sheikh Ali Damoush, Sheikh Ali Damoush (tax fncact advisers, tax fncact veterans)

    Recorded role: co mention · TAX_FNCACT_ADVISERS

    Open source ↗
  2. Cancer vaccine significantly reduces chance of melanoma patients’ tumours returning, results show

    Recorded role: co mention · UNGP_FORESTS_RIVERS_OCEANS

    Open source ↗
  3. Personalized mRNA Melanoma Vaccine Cut Recurrence or Death Risk 42% in Phase 3 Trial, but Survival Data Pending

    Recorded role: co mention · TAX_ECON_PRICE

    Open source ↗
  4. An mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

    Recorded role: co mention · TAX_FNCACT_DEPUTY

    Open source ↗
  5. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · MEDICAL

    Open source ↗
  6. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · TAX_DISEASE_RECURRENCE

    Open source ↗
  7. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · CRISISLEX_CRISISLEXREC

    Open source ↗
  8. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · TAX_DISEASE_TUMOR

    Open source ↗
  9. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · TAX_DISEASE_CANCER

    Open source ↗
  10. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · TAX_DISEASE_FEVER

    Open source ↗
  11. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · CRISISLEX_CRISISLEXREC

    Open source ↗
  12. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · TAX_DISEASE_FEVER

    Open source ↗
  13. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · CRISISLEX_CRISISLEXREC

    Open source ↗
  14. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · CRISISLEX_CRISISLEXREC

    Open source ↗
  15. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · SCIENCE

    Open source ↗
  16. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · TAX_DISEASE_RECURRENCE

    Open source ↗
  17. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · CRISISLEX_C03_WELLBEING_HEALTH

    Open source ↗
  18. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · CRISISLEX_C03_WELLBEING_HEALTH

    Open source ↗
  19. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · TAX_DISEASE_CANCER

    Open source ↗
  20. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · WB_1331_HEALTH_TECHNOLOGIES

    Open source ↗
  21. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · SCIENCE

    Open source ↗
  22. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · CRISISLEX_C03_WELLBEING_HEALTH

    Open source ↗
  23. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · TAX_DISEASE_CANCER

    Open source ↗
  24. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · MEDICAL

    Open source ↗
  25. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · TAX_DISEASE_FEVER

    Open source ↗
  26. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · TAX_DISEASE_TUMOR

    Open source ↗
  27. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · WB_1331_HEALTH_TECHNOLOGIES

    Open source ↗
  28. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · TAX_DISEASE_TUMOR

    Open source ↗
  29. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · CRISISLEX_C03_WELLBEING_HEALTH

    Open source ↗
  30. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · WB_1331_HEALTH_TECHNOLOGIES

    Open source ↗
  31. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · TAX_DISEASE_FEVER

    Open source ↗
  32. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · TAX_DISEASE_CANCER

    Open source ↗
  33. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · CRISISLEX_CRISISLEXREC

    Open source ↗
  34. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · WB_1331_HEALTH_TECHNOLOGIES

    Open source ↗
  35. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · TAX_DISEASE_TUMOR

    Open source ↗
  36. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · TAX_DISEASE_RECURRENCE

    Open source ↗
  37. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · MEDICAL

    Open source ↗
  38. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · WB_1331_HEALTH_TECHNOLOGIES

    Open source ↗
  39. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · TAX_DISEASE_TUMOR

    Open source ↗
  40. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · TAX_DISEASE_TUMOR

    Open source ↗
  41. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · SCIENCE

    Open source ↗
  42. Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial

    Recorded role: co mention · SCIENCE

    Open source ↗
  43. A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning - WCCB Charlotte

    Recorded role: co mention · TAX_FNCACT_DEPUTY

    Open source ↗
  44. Doctors call Moderna, Merck cancer vaccine data a major advancement — despite Wall Street reaction

    Recorded role: co mention · TAX_FNCACT_INVESTOR

    Open source ↗
  45. Novel mRNA cancer vaccine helps reduce chances of melanoma patients' tumors returning

    Recorded role: co mention · GENERAL_HEALTH

    Open source ↗
  46. A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

    Recorded role: co mention · TAX_FNCACT_SUPPORTERS

    Open source ↗
  47. Novel mRNA cancer vaccine developed by Cambridge drugmaker helps keep melanoma tumors at bay

    Recorded role: co mention · TAX_DISEASE_TUMOR

    Open source ↗
  48. Novel mRNA cancer vaccine helps reduce chances of melanoma patients' tumors returning

    Recorded role: co mention · TAX_FNCACT_DOCTORS

    Open source ↗
  49. Experimental mRNA cancer vaccine cuts risk of melanoma returning by 42%: 'A new frontier'

    Recorded role: co mention · GENERAL_HEALTH

    Open source ↗
  50. Experimental mRNA cancer vaccine cuts risk of melanoma returning by 42%: 'A new frontier'

    Recorded role: co mention · TAX_DISEASE_WHOOPING_COUGH

    Open source ↗
  51. Experimental mRNA cancer vaccine cuts risk of melanoma returning by 42%: 'A new frontier'

    Recorded role: co mention · WB_1331_HEALTH_TECHNOLOGIES

    Open source ↗
  52. Experimental mRNA cancer vaccine cuts risk of melanoma returning by 42%: 'A new frontier'

    Recorded role: co mention · UNGP_FORESTS_RIVERS_OCEANS

    Open source ↗
  53. Experimental mRNA cancer vaccine cuts risk of melanoma returning by 42%: 'A new frontier'

    Recorded role: co mention · TAX_FNCACT_DEPUTY

    Open source ↗
  54. Experimental mRNA cancer vaccine cuts risk of melanoma returning by 42%: 'A new frontier'

    Recorded role: co mention · TAX_DISEASE_RECURRENCE

    Open source ↗
  55. AP News in Brief at 12:04 a.m. EDT

    Recorded role: co mention · TAX_FNCACT_ATTORNEY

    Open source ↗
  56. AP News in Brief at 12:04 a.m. EDT

    Recorded role: co mention · TAX_FNCACT_ATTORNEY

    Open source ↗
  57. AP News in Brief at 12:04 a.m. EDT

    Recorded role: co mention · TAX_FNCACT_ATTORNEY

    Open source ↗
  58. An mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

    Recorded role: co mention · TAX_DISEASE_COUGH

    Open source ↗
  59. AP News in Brief at 11:04 p.m. EDT

    Recorded role: co mention · TAX_FNCACT_ATTORNEY

    Open source ↗
  60. An mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

    Recorded role: co mention · GENERAL_HEALTH

    Open source ↗
  61. An mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

    Recorded role: co mention · TAX_DISEASE_COUGH

    Open source ↗
  62. An mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

    Recorded role: co mention · TAX_DISEASE_COVID_19

    Open source ↗
  63. An mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

    Recorded role: co mention · TAX_DISEASE_MEASLES

    Open source ↗
  64. An mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

    Recorded role: co mention · TAX_DISEASE_CORONAVIRUS

    Open source ↗
  65. An mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

    Recorded role: co mention · SCIENCE

    Open source ↗
  66. AP News in Brief at 9:04 p.m. EDT

    Recorded role: co mention · TAX_FNCACT_ATTORNEY

    Open source ↗
  67. A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

    Recorded role: co mention · TAX_FNCACT_AUTHORITIES

    Open source ↗
  68. mRNA cancer vaccine slashes melanoma death or recurrence risk by 42%

    Recorded role: co mention · CRISISLEX_C03_WELLBEING_HEALTH

    Open source ↗
  69. An mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

    Recorded role: co mention · MEDICAL

    Open source ↗
  70. A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

    Recorded role: co mention · MEDICAL

    Open source ↗
  71. A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

    Recorded role: co mention · TAX_DISEASE_MELANOMA

    Open source ↗
  72. A novel mRNA cancer vaccine helps reduce the chances of melanoma patients’ tumors returning - myMotherLode.com

    Recorded role: co mention · TAX_DISEASE_MELANOMA

    Open source ↗
  73. Moderna shares plunge after cancer vaccine data leaks — despite - 博客 | 文学城

    Recorded role: co mention · TAX_DISEASE_RENAL_CELL_CARCINOMA

    Open source ↗
  74. Merck/Moderna cancer vaccine cuts melanoma death or recurrence risk by 42%, shares fall

    Recorded role: co mention · CRISISLEX_CRISISLEXREC

    Open source ↗
  75. A novel mRNA cancer vaccine helps reduce the chances of melanoma patients’ tumors returning

    Recorded role: co mention · CRISISLEX_T11_UPDATESSYMPATHY

    Open source ↗
  76. A novel mRNA cancer vaccine helps reduce the chances of melanoma patients’ tumors returning

    Recorded role: co mention · TAX_FNCACT_DIRECTOR

    Open source ↗
  77. Moderna, Merck shares fall on eagerly anticipated cancer vaccine results

    Recorded role: co mention · GENERAL_HEALTH

    Open source ↗
  78. A novel mRNA cancer vaccine helps reduce the chances of melanoma patients’ tumors returning

    Recorded role: co mention · CRISISLEX_C03_WELLBEING_HEALTH

    Open source ↗
  79. A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

    Recorded role: co mention · CRISISLEX_C03_WELLBEING_HEALTH

    Open source ↗
  80. A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

    Recorded role: co mention · TAX_DISEASE_HEPATITIS_B

    Open source ↗
  81. A novel mRNA cancer vaccine helps reduce the chances of melanoma patients’ tumors returning

    Recorded role: co mention · TAX_DISEASE_HEPATITIS

    Open source ↗
  82. A novel mRNA cancer vaccine helps reduce the chances of melanoma patients’ tumors returning

    Recorded role: co mention · TAX_DISEASE_INFECTION

    Open source ↗
  83. A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

    Recorded role: co mention · TAX_DISEASE_CANCER

    Open source ↗
  84. Gulf recalibrates security amid Saudi-Houthi conflict--China Economic Net

    Recorded role: co mention · TAX_FNCACT_ANALYST

    Open source ↗
  85. arabherald.com: Yazeed Al-Jeddawy, Thabet Hussein, Abu Dhabi (tax aidgroups international crisis group, epu uncertainty)

    Recorded role: co mention · TAX_AIDGROUPS_INTERNATIONAL_CRISIS_GROUP

    Open source ↗
  86. News Analysis: Gulf recalibrates security amid Saudi-Houthi conflict

    Recorded role: co mention · TAX_FNCACT_DIRECTOR

    Open source ↗
  87. News Analysis: Gulf recalibrates security amid Saudi-Houthi conflict

    Recorded role: co mention · ALLIANCE

    Open source ↗
  88. News Analysis: Gulf recalibrates security amid Saudi-Houthi conflict

    Recorded role: co mention · CRISISLEX_CRISISLEXREC

    Open source ↗
  89. News Analysis: Gulf recalibrates security amid Saudi-Houthi conflict

    Recorded role: co mention · CRISISLEX_CRISISLEXREC

    Open source ↗
  90. middleeaststar.com: Ahmed Naji, Abu Dhabi, Abu Dhabi (tax fncact mediator, general government)

    Recorded role: co mention · TAX_FNCACT_MEDIATOR

    Open source ↗
  91. News from the world of Education: October 21, 2026

    Recorded role: co mention · TAX_FNCACT_WOMEN

    Open source ↗

Signals to inspect

Anomalies

Latest 10 in the selected window (up to 10). Detector output, not verified conclusions.

high · volume spike

Volume spike: 9 events in window (6.7x baseline of 1.4 expected)

critical · coordination signal

Coordination signal: co-actor 60406afe-46a1-536f-bbd4-c96d9b4176fb appeared in 8 of 9 window events (89%)

medium · volume spike

Volume spike: 6 events in window (4.8x baseline of 1.3 expected)

high · volume spike

Volume spike: 7 events in window (5.5x baseline of 1.3 expected)

critical · coordination signal

Coordination signal: co-actor 60406afe-46a1-536f-bbd4-c96d9b4176fb appeared in 5 of 6 window events (83%)

critical · coordination signal

Coordination signal: co-actor 60406afe-46a1-536f-bbd4-c96d9b4176fb appeared in 14 of 15 window events (93%)

critical · volume spike

Volume spike: 15 events in window (12.5x baseline of 1.2 expected)

critical · volume spike

Volume spike: 11 events in window (10.5x baseline of 1.0 expected)

critical · coordination signal

Coordination signal: co-actor 60406afe-46a1-536f-bbd4-c96d9b4176fb appeared in 7 of 8 window events (88%)

high · volume spike

Volume spike: 8 events in window (8.0x baseline of 1.0 expected)

Narrative context

Unresolved threads

Latest 20 at most, across all dates. Stored narratives require human review.

No unresolved threads recorded.

Stored connections

Relationships

Up to 50 records ordered by evidence count, across all dates. Co-mentions indicate association in source material, not affiliation or coordination.

Identity is the existing actor registry record. Entity resolution and source coverage may be incomplete.